Press Releases

-Horizon Platform Originates $118 Million of New Loans in Q4, Including $80 Million of New Loans for HRZN - -HRZN Grows Loan Portfolio by $109 Million in 2021 - -Horizon Platform Ends 2021 with Committed Backlog of $153 Million, Including $125 Million in HRZN Commitments - FARMINGTON, Conn. , Jan....

FARMINGTON, Conn. , Jan. 11, 2022 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and...

FARMINGTON, Conn. , Nov. 29, 2021 /PRNewswire/ -- Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information and...

FARMINGTON, Conn. , Oct. 26, 2021 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...

- Net Investment Income per Share of $0.40; NAV per Share of $11.63 - - Debt Portfolio Yield of 16.2% - - Declares Regular Monthly Distributions of $0.10 per Share through March 2022 and $0.05 Special Distribution Payable in December 2021 - - Grew Portfolio to Record $452 Million - FARMINGTON,...

FARMINGTON, Conn. , Oct. 12, 2021 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon") (the "Company"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science,...

- Horizon Platform Originates Record $141 Million of New Loans - - Record $99 Million of Originations for HRZN - - Horizon Platform Committed Backlog of $123 Million; $101 Million in HRZN Commitments - FARMINGTON, Conn. , Oct. 6, 2021 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ:...

BOSTON , Oct. 4, 2021 /PRNewswire/ -- Stealth BioTherapeutics Corp (Nasdaq: MITO), a clinical-stage biotechnology company focused on the discovery, development, and commercialization of novel therapies for diseases involving mitochondrial dysfunction, today announced completion of a $25 million...

FARMINGTON, Conn. , Sept. 28, 2021 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information...

FARMINGTON, Conn. , Sept. 27, 2021 /PRNewswire/ --  Horizon Technology Finance Corporation (NASDAQ: HRZN) ("Horizon"), a leading specialty finance company that provides capital in the form of secured loans to venture capital backed companies in the technology, life science, healthcare information...